BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 29394615)

  • 1. [A Case of Gastric Cancer with Peritoneal Dissemination Effectively Treated with Ramucirumab and Paclitaxel].
    Seo S; Suzuki T; Misumi T; Tashiro H
    Gan To Kagaku Ryoho; 2017 Nov; 44(12):1305-1307. PubMed ID: 29394615
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Weekly paclitaxel plus ramucirumab versus weekly nab-paclitaxel plus ramucirumab for unresectable advanced or recurrent gastric cancer with peritoneal dissemination refractory to first-line therapy-the P-SELECT trial (WJOG10617G)-a randomised phase II trial by the West Japan Oncology Group.
    Hirata K; Hamamoto Y; Ando M; Imamura CK; Yoshimura K; Yamazaki K; Hironaka S; Muro K
    BMC Cancer; 2020 Jun; 20(1):548. PubMed ID: 32532230
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A Case of Advanced Gastric Cancer with Peritoneal Dissemination after Gastrectomy Effectively Treated with Combination Chemotherapy of Ramucirumab and Paclitaxel].
    Muroya T; Wajima N; Kubo N; Yoshida E; Akaishi T; Umetsu S; Yoshida T; Wakasa Y; Sato K; Mitsuhashi Y; Umemura K; Ogasawara H; Hara Y; Hakamada K
    Gan To Kagaku Ryoho; 2018 Dec; 45(13):2066-2068. PubMed ID: 30692286
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A long-surviving patient with unresectable advanced gastric cancer treated with S-1 and biweekly paclitaxel combination chemotherapy as second-line treatment].
    Oneyama M; Sekikawa K; Goto M; Kitamura M; Kawahara Y; Ohta R; Takahashi Y; Hirata Y; Nakayama M; Shimoda Y
    Gan To Kagaku Ryoho; 2012 Jul; 39(7):1131-3. PubMed ID: 22790054
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A Case of Recurrent Gastric Cancer with Grade 3 Proteinuria Caused by Ramucirumab plus Paclitaxel Therapy].
    Kimura Y; Makari Y; Mikami J; Hiraki Y; Kato H; Iwama M; Shiraishi O; Yasuda A; Shinkai M; Imano M; Imamoto H; Fujita J; Furukawa H; Yasuda T
    Gan To Kagaku Ryoho; 2017 Nov; 44(12):1080-1082. PubMed ID: 29394540
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A case of recurrent gastric cancer with peritoneal dissemination responding to doxifluridine/paclitaxel combination chemotherapy as third-line treatment].
    Yagi Y; Ichikawa K; Takahashi K; Okuda N
    Gan To Kagaku Ryoho; 2007 Feb; 34(2):261-3. PubMed ID: 17301540
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A case of gastric cancer with peritoneal dissemination who achieved long survival by successive treatments with S-1 in combination with CDDP, paclitaxel and irinotecan].
    Seshimo K; Kanagawa T; Yamashita Y; Oishi M; Kodera M; Yamamura M; Katoh H; Ikeda H; Yokomichi N; Kobayashi K; Takita K
    Gan To Kagaku Ryoho; 2009 Oct; 36(10):1741-4. PubMed ID: 19838039
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Retrospective comparison of nab-paclitaxel plus ramucirumab and paclitaxel plus ramucirumab as second-line treatment for advanced gastric cancer focusing on peritoneal metastasis.
    Ishikawa M; Iwasa S; Nagashima K; Aoki M; Imazeki H; Hirano H; Shoji H; Honma Y; Okita N; Takashima A; Kato K; Saruta M; Boku N
    Invest New Drugs; 2020 Apr; 38(2):533-540. PubMed ID: 31264067
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Two cases of advanced gastric cancer with peritonitis carcinomatosa that showed disappearance of ascites and obtained a good quality of life by using DIF and paclitaxel].
    Okumura K; Tani S; Shiogai Y; Kodama M; Mekata E; Tan T
    Gan To Kagaku Ryoho; 2012 Apr; 39(4):667-70. PubMed ID: 22504699
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A Case of an Elderly Patient with Unresectable Gastric Cancer Treated by Paclitaxel and Ramucirumab].
    Kimura Y; Makari Y; Mikami J; Yoshimura J; Inoue T; Sawada G; Nakahira S; Yamamura J; Kamigaki S; Nakata K; Yamamoto T; Ikeda N; Tsujie M; Fujita J; Ohzato H
    Gan To Kagaku Ryoho; 2016 Nov; 43(12):2404-2406. PubMed ID: 28133336
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A case of gastric cancer with peritoneal dissemination responding to combination chemotherapy with oral fluoropyrimidine and weekly paclitaxel].
    Tokunaga Y; Sasaki H; Saitou T
    Gan To Kagaku Ryoho; 2008 Jun; 35(6):999-1001. PubMed ID: 18633233
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A case of unresectable Stage IV HER2-positive advanced gastric cancer treated by using trastuzumab combined with chemotherapy].
    Aomatsu N; Doi Y; Takemura S; Tanaka H; Muguruma K; Yui S; Hirakawa K
    Gan To Kagaku Ryoho; 2014 Oct; 41(10):1316-8. PubMed ID: 25335729
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A case of gastric cancer with intensive peritoneal dissemination treated with long-term chemotherapy and surgery].
    Shirai J; Cho H; Fujikawa H; Iwasaki K; Ogata T; Yoshikawa T; Tsuburaya A; Sujishi K; Yamada T; Osaragi T; Yoneyama K; Kasahara A; Yamamoto Y; Rino Y; Masuda M
    Gan To Kagaku Ryoho; 2013 Nov; 40(12):2194-6. PubMed ID: 24394057
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Salvage gastrectomy after intravenous and intraperitoneal paclitaxel (PTX) administration with oral S-1 for peritoneal dissemination of advanced gastric cancer with malignant ascites.
    Kitayama J; Ishigami H; Yamaguchi H; Yamashita H; Emoto S; Kaisaki S; Watanabe T
    Ann Surg Oncol; 2014 Feb; 21(2):539-46. PubMed ID: 23975319
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Successful Long-term Management with a Single Administration of Tri-weekly Nab-paclitaxel in a Patient with Advanced Gastric Cancer with Peritoneal Dissemination.
    Matano D; Moriwaki T; Tange Y; Niisato Y; Yamaura M; Nagase M; Suganuma D; Takagi Taketa K; Iwai K; Enami C; Yamamoto Y; Hyodo I
    Intern Med; 2017; 56(8):921-923. PubMed ID: 28420840
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A Patient with Gastric Cancer with Peritoneal Dissemination Who Survived for Five Years after Sequential Chemotherapy with S-1 Followed by Paclitaxel].
    Urano S; Kakiuchi Y; Takashima H
    Gan To Kagaku Ryoho; 2016 Feb; 43(2):251-4. PubMed ID: 27067693
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A case of recurrent gastric cancer effectively treated by combined chemotherapy of weekly paclitaxel (PTX) and CDDP].
    Hayashi T; Yoshizawa M; Watanabe N; Murayama Y; Shimizu H
    Gan To Kagaku Ryoho; 2006 Aug; 33(8):1167-9. PubMed ID: 16912542
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Advanced stomach and pancreas cancer successfully treated with combination chemotherapy with S-1/paclitaxel/lentinan.
    Kubota E; Kataoka H; Hayashi K; Kamiya T; Sasaki M; Ogasawara N; Yamada T; Wada T; Mori Y; Mizoshita T; Shimura T; Mizushima T; Okamoto Y; Ohara H; Joh T
    Hepatogastroenterology; 2009; 56(89):106-10. PubMed ID: 19453038
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A recurrent gastric cancer with peritoneal metastasis 15 years after distal gastrectomy successfully treated with S-1 and weekly intravenous and intraperitoneal injections of Paclitaxel].
    Iwai N; Wakabayashi N; Matsumoto N; Morita Y; Tanaka N; Yoriki H; Fujii K; Takada R; Takaya H; Masuzawa A; Takami S; Kataoka K
    Gan To Kagaku Ryoho; 2015 Mar; 42(3):351-4. PubMed ID: 25812506
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A case of unresectable HER2-positive advanced gastric cancer successfully treated by combination therapy with trastuzumab and paclitaxel].
    Ojima E; Nishimura G; Nishijima K; Futagami F; Nakamura T; Hosokawa A
    Gan To Kagaku Ryoho; 2012 Nov; 39(12):2339-41. PubMed ID: 23268070
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.